Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 4 of 4 entries
Sorted by: Best Match Show Resources per page
Comparing efficacy and side effects of two systemic chemotherapy regimens for eye-preserving therapy in children with retinoblastoma.

Pediatric blood & cancer

Grümme L, Biewald E, Reschke M, Fischhuber K, Hanbücken A, Schlüter S, Müller B, Kiefer T, Göricke S, Geismar D, Ryl T, Sirin S, Wieland R, Timmermann B, Lohmann D, Ebinger M, Brecht IB, Schönberger S, Schwab C, Eggert A, Süsskind D, Ritter-Sovinz P, Bechrakis NE, Ketteler P.
PMID: 34606174
Pediatr Blood Cancer. 2022 Feb;69(2):e29362. doi: 10.1002/pbc.29362. Epub 2021 Oct 04.

BACKGROUND: Eye-preserving therapy in retinoblastoma comprises systemic chemotherapy, but studies analyzing the efficacy of different chemotherapy regimens are scarce.METHODS: The efficacy and side effects of two different eye-preserving chemotherapy regimens containing either vincristine, etoposide, and carboplatin (VEC) or cyclophosphamide,...

Cite
Grümme L, Biewald E, Reschke M, et al. Comparing efficacy and side effects of two systemic chemotherapy regimens for eye-preserving therapy in children with retinoblastoma. Pediatr Blood Cancer. 2021;69(2):e29362doi: 10.1002/pbc.29362.
Grümme, L., Biewald, E., Reschke, M., Fischhuber, K., Hanbücken, A., Schlüter, S., Müller, B., Kiefer, T., Göricke, S., Geismar, D., Ryl, T., Sirin, S., Wieland, R., Timmermann, B., Lohmann, D., Ebinger, M., Brecht, I. B., Schönberger, S., Schwab, C., Eggert, A., Süsskind, D., Ritter-Sovinz, P., Bechrakis, N. E., & Ketteler, P. (2022). Comparing efficacy and side effects of two systemic chemotherapy regimens for eye-preserving therapy in children with retinoblastoma. Pediatric blood & cancer, 69(2), e29362. https://doi.org/10.1002/pbc.29362
Grümme, Lea, et al. "Comparing efficacy and side effects of two systemic chemotherapy regimens for eye-preserving therapy in children with retinoblastoma." Pediatric blood & cancer vol. 69,2 (2022): e29362. doi: https://doi.org/10.1002/pbc.29362
Grümme L, Biewald E, Reschke M, Fischhuber K, Hanbücken A, Schlüter S, Müller B, Kiefer T, Göricke S, Geismar D, Ryl T, Sirin S, Wieland R, Timmermann B, Lohmann D, Ebinger M, Brecht IB, Schönberger S, Schwab C, Eggert A, Süsskind D, Ritter-Sovinz P, Bechrakis NE, Ketteler P. Comparing efficacy and side effects of two systemic chemotherapy regimens for eye-preserving therapy in children with retinoblastoma. Pediatr Blood Cancer. 2022 Feb;69(2):e29362. doi: 10.1002/pbc.29362. Epub 2021 Oct 04. PMID: 34606174.
Copy Download .nbib Format: NLM
Travel burden and clinical presentation of retinoblastoma: analysis of 1024 patients from 43 African countries and 518 patients from 40 European countries.

The British journal of ophthalmology

Fabian ID, Stacey AW, Foster A, Kivelä TT, Munier FL, Keren-Froim N, Gomel N, Cassoux N, Sagoo MS, Reddy MA, Harby LA, Zondervan M, Bascaran C, Abdallah E, Abdullahi SU, Boubacar SA, Ademola-Popoola DS, Adio A, Aghaji AE, Portabella SA, Alfa Bio AI, Ali AM, Alia DB, All-Eriksson C, Almeida AA, Alsawidi KM, Antonino R, Astbury NJ, Atsiaya R, Balaguer J, Balwierz W, Barranco H, Popovic MB, Benmiloud S, Guebessi NB, Berete RC, Biddulph SJ, Biewald EM, Blum S, Bobrova N, Boehme M, Bornfeld N, Bouda GC, Bouguila H, Boumedane A, Brichard BG, L MC, Castela G, Català-Mora J, Chantada GL, Chernodrinska VS, Chiwanga FS, Cieslik K, Comsa C, Correa Llano MG, Csóka M, Da Gama IV, Davidson A, Potter P, Desjardins L, Dragomir MD, Bruyn MD, Kettani AE, Elbahi AM, Elgalaly D, Elhaddad AM, Ali Elhassan MM, Elzembely MM, Essuman VA, Evina TGA, Fasina O, Fernández-Teijeiro A, Gandiwa M, Aldana DG, Geel JA, Gizachew Z, Gregersen PA, Guedenon KM, Hadjistilianou T, Hassan S, Hederova S, Hessissen L, Hordofa DF, Hummlen M, Husakova K, Ida R, Ilic VR, Jenkinson H, Amani Kabesha TB, Kabore RL, Kalinaki A, Kapelushnik N, Kardava T, Kemilev PK, Kepak T, Khotenashvili Z, Klett A, Kosh Komba Palet JE, Krivaitiene D, Kruger M, Kyara A, Lachmann ES, Latinović S, Lecuona K, Lukamba RM, Lumbroso L, Lysytsia L, Maka E, Makan M, Manda C, Begue NM, Matende IO, Matua M, Mayet I, Mbumba FB, Mengesha AA, Midena E, Mndeme FG, Mohamedani AA, Moll AC, Moreira C, Msina MS, Msukwa G, Muma KI, Murgoi G, Musa KO, Mustak H, Muyen OM, Naidu G, Naumenko L, Ndoye Roth PA, Neroev V, Nikitovic M, Nkanga ED, Nkumbe H, Nyaywa M, Obono-Obiang G, Oguego NC, Olechowski A, Oscar AH, Osei-Bonsu P, Painter SL, Paintsil V, Paiva L, Papyan R, Parrozzani R, Parulekar M, Pawinska-Wasikowska K, Perić S, Philbert R, Pochop P, Polyakov VG, Pompe MT, Pons JJ, Raobela L, Renner LA, Reynders D, Ribadu D, Riheia MM, Ritter-Sovinz P, Saakyan S, Said AM, Román Pacheco SS, Scanlan TA, Schoeman J, Seregard S, Sherief ST, Cheikh SS, Silva S, Sorochynska T, Ssali G, Stathopoulos C, Kranjc BS, Stones DK, Svojgr K, Sylla F, Tamamyan G, Tandili A, Tateshi B, Theophile T, Traoré F, Tyau-Tyau H, Umar AB, Urbak SF, Ushakova TL, Valeina S, Hoefen Wijsard MV, Veleva-Krasteva NV, Viksnins M, Wackernagel W, Waddell K, Wade PD, Wali Nigeria AH, Wime AD, Dod CW, Yanga JM, Yarovaya VA, Yarovoy AA, Zein E, Sharabi S, Zhilyaeva K, Ziko OA, Bowman R.
PMID: 32933936
Br J Ophthalmol. 2021 Oct;105(10):1435-1443. doi: 10.1136/bjophthalmol-2020-316613. Epub 2020 Sep 15.

BACKGROUND: The travel distance from home to a treatment centre, which may impact the stage at diagnosis, has not been investigated for retinoblastoma, the most common childhood eye cancer. We aimed to investigate the travel burden and its impact...

Cite
Fabian ID, Stacey AW, Foster A, et al. Travel burden and clinical presentation of retinoblastoma: analysis of 1024 patients from 43 African countries and 518 patients from 40 European countries. Br J Ophthalmol. 2020;105(10):1435-1443doi: 10.1136/bjophthalmol-2020-316613.
Fabian, I. D., Stacey, A. W., Foster, A., Kivelä, T. T., Munier, F. L., Keren-Froim, N., Gomel, N., Cassoux, N., Sagoo, M. S., Reddy, M. A., Harby, L. A., Zondervan, M., Bascaran, C., Abdallah, E., Abdullahi, S. U., Boubacar, S. A., Ademola-Popoola, D. S., Adio, A., Aghaji, A. E., Portabella, S. A., Alfa Bio, A. I., Ali, A. M., Alia, D. B., All-Eriksson, C., Almeida, A. A., Alsawidi, K. M., Antonino, R., Astbury, N. J., Atsiaya, R., Balaguer, J., Balwierz, W., Barranco, H., Popovic, M. B., Benmiloud, S., Guebessi, N. B., Berete, R. C., Biddulph, S. J., Biewald, E. M., Blum, S., Bobrova, N., Boehme, M., Bornfeld, N., Bouda, G. C., Bouguila, H., Boumedane, A., Brichard, B. G., L, M. C., Castela, G., Català-Mora, J., Chantada, G. L., Chernodrinska, V. S., Chiwanga, F. S., Cieslik, K., Comsa, C., Correa Llano, M. G., Csóka, M., Da Gama, I. V., Davidson, A., Potter, P., Desjardins, L., Dragomir, M. D., Bruyn, M. D., Kettani, A. E., Elbahi, A. M., Elgalaly, D., Elhaddad, A. M., Ali Elhassan, M. M., Elzembely, M. M., Essuman, V. A., Evina, T. G. A., Fasina, O., Fernández-Teijeiro, A., Gandiwa, M., Aldana, D. G., Geel, J. A., Gizachew, Z., Gregersen, P. A., Guedenon, K. M., Hadjistilianou, T., Hassan, S., Hederova, S., Hessissen, L., Hordofa, D. F., Hummlen, M., Husakova, K., Ida, R., Ilic, V. R., Jenkinson, H., Amani Kabesha, T. B., Kabore, R. L., Kalinaki, A., Kapelushnik, N., Kardava, T., Kemilev, P. K., Kepak, T., Khotenashvili, Z., Klett, A., Kosh Komba Palet, J. E., Krivaitiene, D., Kruger, M., Kyara, A., Lachmann, E. S., Latinović, S., Lecuona, K., Lukamba, R. M., Lumbroso, L., Lysytsia, L., Maka, E., Makan, M., Manda, C., Begue, N. M., Matende, I. O., Matua, M., Mayet, I., Mbumba, F. B., Mengesha, A. A., Midena, E., Mndeme, F. G., Mohamedani, A. A., Moll, A. C., Moreira, C., Msina, M. S., Msukwa, G., Muma, K. I., Murgoi, G., Musa, K. O., Mustak, H., Muyen, O. M., Naidu, G., Naumenko, L., Ndoye Roth, P. A., Neroev, V., Nikitovic, M., Nkanga, E. D., Nkumbe, H., Nyaywa, M., Obono-Obiang, G., Oguego, N. C., Olechowski, A., Oscar, A. H., Osei-Bonsu, P., Painter, S. L., Paintsil, V., Paiva, L., Papyan, R., Parrozzani, R., Parulekar, M., Pawinska-Wasikowska, K., Perić, S., Philbert, R., Pochop, P., Polyakov, V. G., Pompe, M. T., Pons, J. J., Raobela, L., Renner, L. A., Reynders, D., Ribadu, D., Riheia, M. M., Ritter-Sovinz, P., Saakyan, S., Said, A. M., Román Pacheco, S. S., Scanlan, T. A., Schoeman, J., Seregard, S., Sherief, S. T., Cheikh, S. S., Silva, S., Sorochynska, T., Ssali, G., Stathopoulos, C., Kranjc, B. S., Stones, D. K., Svojgr, K., Sylla, F., Tamamyan, G., Tandili, A., Tateshi, B., Theophile, T., Traoré, F., Tyau-Tyau, H., Umar, A. B., Urbak, S. F., Ushakova, T. L., Valeina, S., Hoefen Wijsard, M. V., Veleva-Krasteva, N. V., Viksnins, M., Wackernagel, W., Waddell, K., Wade, P. D., Wali Nigeria, A. H., Wime, A. D., Dod, C. W., Yanga, J. M., Yarovaya, V. A., Yarovoy, A. A., Zein, E., Sharabi, S., Zhilyaeva, K., Ziko, O. A., & Bowman, R. (2021). Travel burden and clinical presentation of retinoblastoma: analysis of 1024 patients from 43 African countries and 518 patients from 40 European countries. The British journal of ophthalmology, 105(10), 1435-1443. https://doi.org/10.1136/bjophthalmol-2020-316613
Fabian, Ido Didi, et al. "Travel burden and clinical presentation of retinoblastoma: analysis of 1024 patients from 43 African countries and 518 patients from 40 European countries." The British journal of ophthalmology vol. 105,10 (2021): 1435-1443. doi: https://doi.org/10.1136/bjophthalmol-2020-316613
Fabian ID, Stacey AW, Foster A, Kivelä TT, Munier FL, Keren-Froim N, Gomel N, Cassoux N, Sagoo MS, Reddy MA, Harby LA, Zondervan M, Bascaran C, Abdallah E, Abdullahi SU, Boubacar SA, Ademola-Popoola DS, Adio A, Aghaji AE, Portabella SA, Alfa Bio AI, Ali AM, Alia DB, All-Eriksson C, Almeida AA, Alsawidi KM, Antonino R, Astbury NJ, Atsiaya R, Balaguer J, Balwierz W, Barranco H, Popovic MB, Benmiloud S, Guebessi NB, Berete RC, Biddulph SJ, Biewald EM, Blum S, Bobrova N, Boehme M, Bornfeld N, Bouda GC, Bouguila H, Boumedane A, Brichard BG, L MC, Castela G, Català-Mora J, Chantada GL, Chernodrinska VS, Chiwanga FS, Cieslik K, Comsa C, Correa Llano MG, Csóka M, Da Gama IV, Davidson A, Potter P, Desjardins L, Dragomir MD, Bruyn MD, Kettani AE, Elbahi AM, Elgalaly D, Elhaddad AM, Ali Elhassan MM, Elzembely MM, Essuman VA, Evina TGA, Fasina O, Fernández-Teijeiro A, Gandiwa M, Aldana DG, Geel JA, Gizachew Z, Gregersen PA, Guedenon KM, Hadjistilianou T, Hassan S, Hederova S, Hessissen L, Hordofa DF, Hummlen M, Husakova K, Ida R, Ilic VR, Jenkinson H, Amani Kabesha TB, Kabore RL, Kalinaki A, Kapelushnik N, Kardava T, Kemilev PK, Kepak T, Khotenashvili Z, Klett A, Kosh Komba Palet JE, Krivaitiene D, Kruger M, Kyara A, Lachmann ES, Latinović S, Lecuona K, Lukamba RM, Lumbroso L, Lysytsia L, Maka E, Makan M, Manda C, Begue NM, Matende IO, Matua M, Mayet I, Mbumba FB, Mengesha AA, Midena E, Mndeme FG, Mohamedani AA, Moll AC, Moreira C, Msina MS, Msukwa G, Muma KI, Murgoi G, Musa KO, Mustak H, Muyen OM, Naidu G, Naumenko L, Ndoye Roth PA, Neroev V, Nikitovic M, Nkanga ED, Nkumbe H, Nyaywa M, Obono-Obiang G, Oguego NC, Olechowski A, Oscar AH, Osei-Bonsu P, Painter SL, Paintsil V, Paiva L, Papyan R, Parrozzani R, Parulekar M, Pawinska-Wasikowska K, Perić S, Philbert R, Pochop P, Polyakov VG, Pompe MT, Pons JJ, Raobela L, Renner LA, Reynders D, Ribadu D, Riheia MM, Ritter-Sovinz P, Saakyan S, Said AM, Román Pacheco SS, Scanlan TA, Schoeman J, Seregard S, Sherief ST, Cheikh SS, Silva S, Sorochynska T, Ssali G, Stathopoulos C, Kranjc BS, Stones DK, Svojgr K, Sylla F, Tamamyan G, Tandili A, Tateshi B, Theophile T, Traoré F, Tyau-Tyau H, Umar AB, Urbak SF, Ushakova TL, Valeina S, Hoefen Wijsard MV, Veleva-Krasteva NV, Viksnins M, Wackernagel W, Waddell K, Wade PD, Wali Nigeria AH, Wime AD, Dod CW, Yanga JM, Yarovaya VA, Yarovoy AA, Zein E, Sharabi S, Zhilyaeva K, Ziko OA, Bowman R. Travel burden and clinical presentation of retinoblastoma: analysis of 1024 patients from 43 African countries and 518 patients from 40 European countries. Br J Ophthalmol. 2021 Oct;105(10):1435-1443. doi: 10.1136/bjophthalmol-2020-316613. Epub 2020 Sep 15. PMID: 32933936.
Copy Download .nbib Format: NLM
Eye Tumors in Childhood as First Sign of Tumor Predisposition Syndromes: Insights from an Observational Study Conducted in Germany and Austria.

Cancers

Reschke M, Biewald E, Bronstein L, Brecht IB, Dittner-Moormann S, Driever F, Ebinger M, Fleischhack G, Grabow D, Geismar D, Göricke S, Guberina M, Le Guin CHD, Kiefer T, Kratz CP, Metz K, Müller B, Ryl T, Schlamann M, Schlüter S, Schönberger S, Schulte JH, Sirin S, Süsskind D, Timmermann B, Ting S, Wackernagel W, Wieland R, Zenker M, Zeschnigk M, Reinhardt D, Eggert A, Ritter-Sovinz P, Lohmann DR, Bornfeld N, Bechrakis N, Ketteler P.
PMID: 33919815
Cancers (Basel). 2021 Apr 14;13(8). doi: 10.3390/cancers13081876.

Retinoblastoma and other eye tumors in childhood are rare diseases. Many eye tumors are the first signs of a genetic tumor predisposition syndrome and the affected children carry a higher risk of developing other cancers later in life. Clinical...

Cite
Reschke M, Biewald E, Bronstein L, et al. Eye Tumors in Childhood as First Sign of Tumor Predisposition Syndromes: Insights from an Observational Study Conducted in Germany and Austria. Cancers (Basel). 2021;13(8)doi: 10.3390/cancers13081876.
Reschke, M., Biewald, E., Bronstein, L., Brecht, I. B., Dittner-Moormann, S., Driever, F., Ebinger, M., Fleischhack, G., Grabow, D., Geismar, D., Göricke, S., Guberina, M., Le Guin, C. H. D., Kiefer, T., Kratz, C. P., Metz, K., Müller, B., Ryl, T., Schlamann, M., Schlüter, S., Schönberger, S., Schulte, J. H., Sirin, S., Süsskind, D., Timmermann, B., Ting, S., Wackernagel, W., Wieland, R., Zenker, M., Zeschnigk, M., Reinhardt, D., Eggert, A., Ritter-Sovinz, P., Lohmann, D. R., Bornfeld, N., Bechrakis, N., & Ketteler, P. (2021). Eye Tumors in Childhood as First Sign of Tumor Predisposition Syndromes: Insights from an Observational Study Conducted in Germany and Austria. Cancers, 13(8), . https://doi.org/10.3390/cancers13081876
Reschke, Madlen, et al. "Eye Tumors in Childhood as First Sign of Tumor Predisposition Syndromes: Insights from an Observational Study Conducted in Germany and Austria." Cancers vol. 13,8 (2021). doi: https://doi.org/10.3390/cancers13081876
Reschke M, Biewald E, Bronstein L, Brecht IB, Dittner-Moormann S, Driever F, Ebinger M, Fleischhack G, Grabow D, Geismar D, Göricke S, Guberina M, Le Guin CHD, Kiefer T, Kratz CP, Metz K, Müller B, Ryl T, Schlamann M, Schlüter S, Schönberger S, Schulte JH, Sirin S, Süsskind D, Timmermann B, Ting S, Wackernagel W, Wieland R, Zenker M, Zeschnigk M, Reinhardt D, Eggert A, Ritter-Sovinz P, Lohmann DR, Bornfeld N, Bechrakis N, Ketteler P. Eye Tumors in Childhood as First Sign of Tumor Predisposition Syndromes: Insights from an Observational Study Conducted in Germany and Austria. Cancers (Basel). 2021 Apr 14;13(8). doi: 10.3390/cancers13081876. PMID: 33919815; PMCID: PMC8070790.
Copy Download .nbib Format: NLM
Comparing efficacy and side effects of two systemic chemotherapy regimens for eye-preserving therapy in children with retinoblastoma.

Pediatric blood & cancer

Grümme L, Biewald E, Reschke M, Fischhuber K, Hanbücken A, Schlüter S, Müller B, Kiefer T, Göricke S, Geismar D, Ryl T, Sirin S, Wieland R, Timmermann B, Lohmann D, Ebinger M, Brecht IB, Schönberger S, Schwab C, Eggert A, Süsskind D, Ritter-Sovinz P, Bechrakis NE, Ketteler P.
PMID: 34606174
Pediatr Blood Cancer. 2021 Oct 04;e29362. doi: 10.1002/pbc.29362. Epub 2021 Oct 04.

BACKGROUND: Eye-preserving therapy in retinoblastoma comprises systemic chemotherapy, but studies analyzing the efficacy of different chemotherapy regimens are scarce.METHODS: The efficacy and side effects of two different eye-preserving chemotherapy regimens containing either vincristine, etoposide, and carboplatin (VEC) or cyclophosphamide,...

Cite
Grümme L, Biewald E, Reschke M, et al. Comparing efficacy and side effects of two systemic chemotherapy regimens for eye-preserving therapy in children with retinoblastoma. Pediatr Blood Cancer. 2021;e29362doi: 10.1002/pbc.29362.
Grümme, L., Biewald, E., Reschke, M., Fischhuber, K., Hanbücken, A., Schlüter, S., Müller, B., Kiefer, T., Göricke, S., Geismar, D., Ryl, T., Sirin, S., Wieland, R., Timmermann, B., Lohmann, D., Ebinger, M., Brecht, I. B., Schönberger, S., Schwab, C., Eggert, A., Süsskind, D., Ritter-Sovinz, P., Bechrakis, N. E., & Ketteler, P. (2021). Comparing efficacy and side effects of two systemic chemotherapy regimens for eye-preserving therapy in children with retinoblastoma. Pediatric blood & cancer, e29362. https://doi.org/10.1002/pbc.29362
Grümme, Lea, et al. "Comparing efficacy and side effects of two systemic chemotherapy regimens for eye-preserving therapy in children with retinoblastoma." Pediatric blood & cancer vol. (2021): e29362. doi: https://doi.org/10.1002/pbc.29362
Grümme L, Biewald E, Reschke M, Fischhuber K, Hanbücken A, Schlüter S, Müller B, Kiefer T, Göricke S, Geismar D, Ryl T, Sirin S, Wieland R, Timmermann B, Lohmann D, Ebinger M, Brecht IB, Schönberger S, Schwab C, Eggert A, Süsskind D, Ritter-Sovinz P, Bechrakis NE, Ketteler P. Comparing efficacy and side effects of two systemic chemotherapy regimens for eye-preserving therapy in children with retinoblastoma. Pediatr Blood Cancer. 2021 Oct 04;e29362. doi: 10.1002/pbc.29362. Epub 2021 Oct 04. PMID: 34606174.
Copy Download .nbib Format: NLM
Showing 1 to 4 of 4 entries